Day One Biopharmaceuticals Inc [NASDAQ: DAWN] Sees Increase in Stock Value
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Day One Biopharmaceuticals Inc shares valued at $160,055 were sold by Blackman Samuel C. on Mar 25 ’24. At $16.01 per share, Blackman Samuel C. sold 10,000 shares. The insider’s holdings dropped to 1,184,662 shares worth approximately […]
Day One Biopharmaceuticals Inc (DAWN) rating downgrades by BofA Securities
Day One Biopharmaceuticals Inc’s recent filing unveils that its HEAD OF R&D Blackman Samuel C. unloaded Company’s shares for reported $0.16 million on Mar 25 ’24. In the deal valued at $16.01 per share,10,000 shares were sold. As a result of this transaction, Blackman Samuel C. now holds 1,184,662 shares worth roughly $16.31 million. Then, […]
Day One Biopharmaceuticals Inc [DAWN] stock for 160,055 USD was sold by Blackman Samuel C.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Day One Biopharmaceuticals Inc shares valued at $160,055 were sold by Blackman Samuel C. on Mar 25 ’24. At $16.01 per share, Blackman Samuel C. sold 10,000 shares. The insider’s holdings […]
Day One Biopharmaceuticals Inc (DAWN) rating downgrades by BofA Securities
In a filing, Day One Biopharmaceuticals Inc revealed its HEAD OF R&D Blackman Samuel C. unloaded Company’s shares for reported $0.16 million on Mar 25 ’24. In the deal valued at $16.01 per share,10,000 shares were sold. As a result of this transaction, Blackman Samuel C. now holds 1,184,662 shares worth roughly $17.26 million. Then, […]
Selling Buzz: Day One Biopharmaceuticals Inc [DAWN] HEAD OF R&D Blackman Samuel C. sells 10,000 shares of the company
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Day One Biopharmaceuticals Inc shares valued at $160,055 were sold by Blackman Samuel C. on Mar 25 ’24. At $16.01 per share, Blackman Samuel C. sold 10,000 shares. The insider’s holdings […]
Recent Insider Activity Suggests Potential Gains for Day One Biopharmaceuticals Inc (DAWN)
Day One Biopharmaceuticals Inc’s recently made public that its HEAD OF R&D Blackman Samuel C. unloaded Company’s shares for reported $0.16 million on Mar 25 ’24. In the deal valued at $16.01 per share,10,000 shares were sold. As a result of this transaction, Blackman Samuel C. now holds 1,184,662 shares worth roughly $19.57 million. Then, […]
DAWN’s short interest falls to 9.61 million shares
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Day One Biopharmaceuticals Inc shares valued at $160,055 were sold by Blackman Samuel C. on Mar 25 ’24. At $16.01 per share, Blackman Samuel C. sold 10,000 shares. The insider’s holdings dropped to 1,184,662 shares worth approximately […]
Understanding the Risks of Investing in Day One Biopharmaceuticals Inc (DAWN)
In a filing, Day One Biopharmaceuticals Inc revealed its HEAD OF R&D Blackman Samuel C. unloaded Company’s shares for reported $0.46 million on Mar 11 ’24. In the deal valued at $15.24 per share,30,000 shares were sold. As a result of this transaction, Blackman Samuel C. now holds 1,194,662 shares worth roughly $18.58 million. Then, […]
